Excalipoint raises $68.7M seed round
4 articles curated from biotech news
Excalipoint closes $68.7M seed round for cancer T-cell engagers
BioWorld (Clarivate)Mar 18, 2026Shanghai biotech Excalipoint gains $68.7M for T cell engagers
Endpoints NewsMar 18, 2026Lilly-Backed China Startup Debuts With $68.7M Seed to Advance Next-Gen T Cell Engagers
BioSpaceMar 18, 2026Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers
BioPharma DiveMar 18, 2026
Want daily biotech news like this? Sign up free